Genetic Profiling for Breast Cancer Risk

Corresponding Organization : University of Cambridge

Other organizations : Cyprus Institute of Neurology and Genetics, Université Laval, The Netherlands Cancer Institute, National Cancer Institute, National Institutes of Health, Helsinki University Hospital, University of Helsinki, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, University of Toronto, University of California, Irvine, N.N. Alexandrov National Cancer Centre, German Cancer Research Center, Heidelberg University, Queen's University, University of Wisconsin–Milwaukee, Fred Hutch Cancer Center, Kuopio University Hospital, University of Eastern Finland, Universitätsklinikum Erlangen, Comprehensive Cancer Center Erlangen, Spanish National Cancer Research Centre, Centre for Biomedical Network Research on Rare Diseases, Russian Academy of Sciences, Institute of Biochemistry and Genetics of Ufa Scientific Centre, City of Hope, Örebro University Hospital, Medizinische Hochschule Hannover, University of Copenhagen, Gentofte Hospital, Copenhagen University Hospital, European Institute of Oncology, Oslo University Hospital, University of Oslo, Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, University of Tübingen, National Center for Tumor Diseases, Queen Mary University of London, University of Sheffield, Simon Fraser University, BC Cancer Agency, Institute for Prevention and Occupational Medicine, University of Pisa, American Cancer Society, Servicio Gallego de Salud, University of California, Los Angeles, Westmead Institute for Medical Research, University of Sydney, Erasmus MC, Centre de recherche en Epidémiologie et Santé des Populations, Inserm, Mayo Clinic, WinnMed, Karolinska Institutet, Fox Chase Cancer Center, Leiden University Medical Center, London School of Hygiene & Tropical Medicine, Centre hospitalier universitaire de Québec, University of Southampton, University of Westminster, Brigham and Women's Hospital, Harvard University, Lund University, Leipzig University, Manchester Academic Health Science Centre, University of Manchester, St Mary's Hospital, Manchester University NHS Foundation Trust, University of Edinburgh, Edinburgh Cancer Research, Breast Cancer Now, Institute of Cancer Research, Curtin University, University of California, San Diego, Instituto de Investigación Sanitaria de Santiago, Fundación Pública Galega de Medicina Xenómica, Complejo Hospitalario Universitario de Santiago, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Centro de Investigación Biomédica en Red de Cáncer, University Hospital of Heraklion, Monash University, University of Melbourne, Cancer Council Victoria, Bashkir State University, McGill University, Royal Victoria Hospital, Huntsman Cancer Institute, University of Utah, Oulu University Hospital, University of Oulu, Pomeranian Medical University, Centre Hospitalier de l’Université de Montréal, University of Cologne, University Hospital Cologne, University of Southern California, University of Massachusetts Amherst, NIHR Manchester Biomedical Research Centre, Wythenshawe Hospital, Mayo Clinic in Florida, University of Western Australia, Erasmus MC Cancer Institute, University of Oxford, Macedonian Academy of Sciences and Arts, University Hospital Ulm, Stanford University, Tampere University, Tampere University Hospital, Central Finland Health Care District, Ollscoil na Gaillimhe – University of Galway, Sinai Health System, Public Health Ontario, Johanniter-Krankenhaus Bonn, University Medical Center Hamburg-Eppendorf, Universität Hamburg, University Cancer Center Hamburg, VIB-KU Leuven Center for Cancer Biology, KU Leuven, University of Hawaiʻi at Mānoa, University of Hawaii System, Cancer Center of Hawaii, Carmel Medical Center, Karolinska University Hospital, University of Washington, The Maria Sklodowska-Curie National Research Institute of Oncology, German Breast group, Vanderbilt University, Fondazione IRCCS Istituto Nazionale dei Tumori, Stockholm South General Hospital, The Alfred Hospital, Ludwig-Maximilians-Universität München, MRC Clinical Trials Unit at UCL, University College London, University Health Network, Sorbonne Paris Cité, University Hospital Complex Of Vigo, Memorial Sloan Kettering Cancer Center, Queen's University Belfast, University of New Mexico, Hospital Monte Naranco, Hospital Universitario Puerta de Hierro Majadahonda, FIRC Institute of Molecular Oncology, Wayne State University, NordLab, Mayo Clinic in Arizona, University Hospital of Larissa, National Institute of Environmental Health Sciences, Guy's Hospital, King's College London, University Hospital Heidelberg, Case Western Reserve University, University of Newcastle Australia, John Hunter Hospital, Hunter Medical Research Institute, Jacksonville College, Monash Health, University of British Columbia, Krebsregister Saarland, Columbia University, Wellcome Centre for Human Genetics, University of Birmingham, Klinikum Mittelbaden, Olgahospital, Helios Hospital Berlin-Buch, Uppsala University, National Centre of Scientific Research "Demokritos", QIMR Berghofer Medical Research Institute, Johns Hopkins University